Literature DB >> 19858462

A cross-sectional study of bone health in multiple sclerosis.

Ruth Ann Marrie1, Gary Cutter, Tuula Tyry, Timothy Vollmer.   

Abstract

BACKGROUND: Osteoporosis is an important risk factor for fragility fractures. Although osteoporosis is considered common in multiple sclerosis (MS), few previous studies focused on fractures in MS.
OBJECTIVE: Using the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry, we investigated the frequency of osteoporosis, fractures, and clinical risk factors for fracture in MS.
METHODS: In 2007, 9,346 NARCOMS participants reported fractures and clinical risk factors for fractures including history of osteoporosis or osteopenia (low bone mass), sedentary level of physical activity, falls in the last year, current smoking status, family history of osteoporosis, and impaired mobility.
RESULTS: Among responders, 2,501 (27.2%) reported low bone mass. More than 15% of responders reported a history of fracture after age 13 years (n = 1,482). Among those reporting fractures, 685 (46.2%) reported multiple fractures, while 522 (35.2%) reported a wrist fracture, 165 (11.1%) reported a vertebral fracture, and 100 (7.4%) reported a hip fracture. Excluding age, 1,413 (15.1%) participants had 1 clinical risk factor for fracture, 2,341 (25.0%) had 2, and 5,393 (57.7%) had 3 or more. Among participants with a history of fracture, 746 (55%) reported taking calcium supplements, 858 (68.8%) reported taking vitamin D supplements or a multivitamin with vitamin D, and 334 (22.5%) reported taking a bisphosphonate.
CONCLUSION: Patients with multiple sclerosis (MS) often have multiple risk factors for osteoporotic fractures. Many patients with MS with low bone mass or previous fractures are not taking supplemental calcium or vitamin D, suggesting a potential area of improvement in care.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19858462      PMCID: PMC2769555          DOI: 10.1212/WNL.0b013e3181beece8

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Multiple sclerosis management for low-income minorities.

Authors:  Debra Shabas; Megan Heffner
Journal:  Mult Scler       Date:  2005-12       Impact factor: 6.312

2.  The accuracy of self-reported fractures in older people.

Authors:  Rebecca Q Ivers; Robert G Cumming; Paul Mitchell; Anthony J Peduto
Journal:  J Clin Epidemiol       Date:  2002-05       Impact factor: 6.437

3.  Leisure, home, and occupational physical activity and cardiovascular risk factors in postmenopausal women. The Postmenopausal Estrogens/Progestins Intervention (PEPI) Study.

Authors:  G A Greendale; L Bodin-Dunn; S Ingles; R Haile; E Barrett-Connor
Journal:  Arch Intern Med       Date:  1996-02-26

4.  Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression.

Authors:  M J Hohol; E J Orav; H L Weiner
Journal:  Mult Scler       Date:  1999-10       Impact factor: 6.312

5.  Americans are not meeting current calcium recommendations.

Authors:  Jun Ma; Rachel A Johns; Randall S Stafford
Journal:  Am J Clin Nutr       Date:  2007-05       Impact factor: 7.045

6.  Fracture history and bone loss in patients with MS.

Authors:  F Cosman; J Nieves; L Komar; G Ferrer; J Herbert; C Formica; V Shen; R Lindsay
Journal:  Neurology       Date:  1998-10       Impact factor: 9.910

7.  Risk of bone loss in men with multiple sclerosis.

Authors:  Bianca Weinstock-Guttman; Eileen Gallagher; Monika Baier; Lydia Green; Joan Feichter; Kara Patrick; Colleen Miller; Kathleen Wrest; Murali Ramanathan
Journal:  Mult Scler       Date:  2004-04       Impact factor: 6.312

8.  Disparities in the management of multiple sclerosis-related bladder symptoms.

Authors:  R A Marrie; G Cutter; T Tyry; T Vollmer; D Campagnolo
Journal:  Neurology       Date:  2007-06-05       Impact factor: 9.910

  8 in total
  22 in total

Review 1.  Evolving concepts in neurogenic osteoporosis.

Authors:  Weiping Qin; William A Bauman; Christopher P Cardozo
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

2.  Asymmetrical hip bone density in multiple sclerosis.

Authors:  Rebecca D Larson; Lesley J White
Journal:  Int J MS Care       Date:  2011

Review 3.  Cardiovascular Autonomic Dysfunction: Link Between Multiple Sclerosis Osteoporosis and Neurodegeneration.

Authors:  Zohara Sternberg
Journal:  Neuromolecular Med       Date:  2018-02-10       Impact factor: 3.843

Review 4.  Impact of the Autonomic Nervous System on the Skeleton.

Authors:  Florent Elefteriou
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 5.  Bone health in multiple sclerosis.

Authors:  J C Gibson; G D Summers
Journal:  Osteoporos Int       Date:  2011-05-21       Impact factor: 4.507

6.  CNS disease diminishes the therapeutic functionality of bone marrow mesenchymal stem cells.

Authors:  Alex Sargent; Lianhua Bai; Genevieve Shano; Molly Karl; Eric Garrison; Lahiru Ranasinghe; Sarah M Planchon; Jeffrey Cohen; Robert H Miller
Journal:  Exp Neurol       Date:  2017-06-09       Impact factor: 5.330

Review 7.  Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

Authors:  S Binks; R Dobson
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

8.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

9.  Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study.

Authors:  Irene Lambrinoudaki; Elias Patikas; George Kaparos; Eleni Armeni; Demetrios Rizos; Pinelopi Thoda; Andreas Alexandrou; Aristidis Antoniou; George Tsivgoulis; Stergios Gatzonis; Constantinos Panoulis; Nikolaos Triantafyllou
Journal:  Neurol Sci       Date:  2012-12-05       Impact factor: 3.307

Review 10.  Osteoporosis and multiple sclerosis: risk factors, pathophysiology, and therapeutic interventions.

Authors:  Sahil Gupta; Irfan Ahsan; Naeem Mahfooz; Noureldin Abdelhamid; Murali Ramanathan; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.